Neurizon Therapeutics (ASX:NUZ) - Key People
ASX:NUZ · Directors, executives and key personnel · 12 month lookback
Sergio Duchini
Current
Interim Executive Chairman
Mentioned in
Healthcare Wrap - Week 25 (15 June -> 19 June) 2026
20 June 2026
Neurizon Locks in Five-Year Supply Deal with Elanco to Boost NUZ-001 Commercialisation
17 June 2026
Healthcare Wrap - Week 24 (8 June -> 12 June) 2026
13 June 2026
Neurizon Passes Halfway Mark in Expanded HEALEY ALS Trial Ahead of Schedule
12 June 2026
Dr Michael Thurn
Current
Managing Director and Chief Executive Officer
Mentioned in
Healthcare Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
Neurizon CEO Steps Down as Interim Chair Takes Helm Amid Global Search
16 Mar 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Neurizon Launches Pivotal Phase 2/3 Trial of NUZ-001 in ALS Patients
26 Feb 2026
Also Mentioned
People named in Neurizon Therapeutics (ASX:NUZ) articles over the last 12 months, by frequency.
Henry Jordan
· 12 articles
Lidija Damjanovic
· 9 articles
Dan O’Connell
· 6 articles
Matthew Selinger
· 5 articles
Justine Conway
· 4 articles
Professor Merit Cudkowicz
· 3 articles
Marcus Hughes
· 3 articles
Katie MacFarlane
· 3 articles
John Clark
· 3 articles
Merit Cudkowicz
· 2 articles
Sabrina Paganoni
· 2 articles
Stefan Ross
· 2 articles
Jeffrey M. Brown
· 2 articles
Sharon Tamir
· 2 articles
Chek Loon Tan
· 1 article
Roger Aston
· 1 article
Stacie Seidel
· 1 article
Josie Hayes
· 1 article
Associate Professor Susan Mathers
· 1 article
Professor Dominic Rowe
· 1 article